ERBA Diagnostics, Inc., a prominent player in the diagnostics industry, is headquartered in the United States and operates extensively across various global regions. Founded in 1988, the company has established itself as a leader in the development and manufacturing of innovative diagnostic solutions, particularly in clinical chemistry and immunology. ERBA Diagnostics offers a diverse range of core products, including advanced analysers and reagents that are distinguished by their reliability and accuracy. The company’s commitment to quality and innovation has earned it a strong market position, with notable achievements in expanding its product portfolio and enhancing customer satisfaction. With a focus on improving healthcare outcomes, ERBA Diagnostics continues to be a trusted partner for laboratories worldwide.
How does ERBA Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ERBA Diagnostics, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ERBA Diagnostics, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary, ERBA Diagnostics, Inc. may inherit climate-related initiatives and targets from its parent organisation, but no specific details are available regarding such cascaded data. The absence of emissions data and reduction initiatives places ERBA Diagnostics, Inc. in a context where it may need to enhance its climate commitments to align with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ERBA Diagnostics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.